ANTIBODIES AGAINST HDLCOMPONENTS IMPROVE THE DIAGNOSTIC ACCURACY BETWEEN ISCHEMIC STROKE OR CORONARY ARTERY DISEASE AND HEALTHY CONTROLS WHEN ADDED TO TRADITIONAL CARDIOVASCULAR RISK FACTORS

Research output: Contribution to journalMeeting Abstract

Original languageEnglish
Pages (from-to)E88-E88
JournalAtherosclerosis
Volume275
Publication statusPublished - Aug 2018

Cite this